Lucy Roalfe
Impact in
- Microbiology top 5%
- Bacterial Infections and Vaccines
- Epidemiology top 5%
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Pneumocystis jirovecii pneumonia detection and treatment
- Influenza Virus Research Studies
Papers in
- Epidemiology 17
- Pneumonia and Respiratory Infections 17
- Respiratory viral infections research 7
- Pneumocystis jirovecii pneumonia detection and treatment 3
-
- Bacterial Infections and Vaccines 4
- Co-authors
- David Goldblatt (18 shared papers)Elizabeth Miller (3 shared papers)Marta Zancolli (5 shared papers)Nick Andrews (3 shared papers)Polly Burbidge (3 shared papers)Emma Pearce (4 shared papers)Mary Slack (1 shared paper)Shamez Ladhani (1 shared paper)
- Journals
- Vaccine (5 papers)Clinical and Vaccine Immunology (3 papers)The Lancet Infectious Diseases (3 papers)mSphere (2 papers)Infection and Immunity (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Lucy Roalfe
19 papers receiving 677 citations
Lucy Roalfe's Hit Papers
Peers
Comparison fields: 5 of 50
- Microbiology 124
- Epidemiology 552
- Immunology 62
- Infectious Diseases 40
- Health 16
Countries citing papers authored by Lucy Roalfe
This map shows the geographic impact of Lucy Roalfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Roalfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Roalfe more than expected).
Fields of papers citing papers by Lucy Roalfe
This network shows the impact of papers produced by Lucy Roalfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Roalfe. The network helps show where Lucy Roalfe may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucy Roalfe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study Hit paper breakdown → | 2014 | 400 |
| 2 | 2017 | 72 | |
| 3 | 2017 | 31 | |
| 4 | 2015 | 24 | |
| 5 | 2017 | 21 | |
| 6 | 2015 | 17 | |
| 7 | 2020 | 17 | |
| 8 | 2016 | 15 | |
| 9 | 2017 | 13 | |
| 10 | 2016 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2018 | 9 | |
| 13 | 2023 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2015 | 6 | |
| 18 | 2015 | 6 | |
| 19 | 2019 | 2 |
About Lucy Roalfe
Lucy Roalfe is a scholar working on Epidemiology, Microbiology, Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 19 papers that have together received 686 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (17 papers), Respiratory viral infections research (7 papers), Bacterial Infections and Vaccines (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), T-cell and B-cell Immunology (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Microbiology (124 citations), Epidemiology (552 citations), Immunology (62 citations), Infectious Diseases (40 citations) and Health (16 citations). Lucy Roalfe has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include David Goldblatt, Elizabeth Miller, Marta Zancolli, Nick Andrews, Polly Burbidge, Emma Pearce, Mary Slack, Shamez Ladhani, Pauline A. Waight and Matthew D. Snape. Their work appears in journals such as Vaccine, Clinical and Vaccine Immunology, The Lancet Infectious Diseases, mSphere and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.